Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
sig12d loder converts the undruggable kras to a drug target shown in ...
sig12d loder halts metastases and attenuates tumor growth in this
LODER characteristics: (A) SEM image of the siG12D LODER removed 45 d ...
siG12D LODER inhibits KRAS expression and growth of orthotopic ...
The silencing effect of the siG12D LODER in human pancreatic cancer ...
LODER (First generation siRNA) Phase 2 Clinical Trial Data 10
siG12D LODER联合化疗治疗KRAS G12D/V突变胰腺癌患者：OS延长9.3个月，ORR 67%！ - 知乎
Mutant KRAS is a druggable target for pancreatic cancer | PNAS
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling ...
Spermine-Based Poly(β-amino ester)s for siRNA Delivery against Mutated ...
KRAS: A Druggable Target in Colon Cancer Patients
Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients?
RNA Silencing Finds Its Therapeutic Voice
siRNA Nanoparticle Delivery Strategies and Clinical Trial Advances in ...
RNA疗法的研究和临床进展 - 药时代DrugTimes
Exhibit 99.1
约KRAS G12C的2.5倍发病率！祐森健恒就KRAS G12D与阿斯利康达成4亿美元全球独家授权_腾讯新闻
Enhanced efficacy and limited systemic cytokine exposure with membrane ...
Translational Imaging Lab (Zhuoli Zhang Lab) – Development of Novel ...
Anchoring of intratumorally administered cytokines to collagen safely ...
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene ...
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
瘤内注射针对 CSFR1 和 PD-L1 的 IL-12 编码 mRNA，无需大量全身暴露即可发挥有效的抗肿瘤作用,Molecular ...
Tumor‐Associated Macrophage and Tumor‐Cell Dually Transfecting ...
Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology ...
Characterization of abscopal effects of intratumoral electroporation ...
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer ...
Bioengineering | Special Issue : Bioengineered Systems: Implants and ...
Cell surface–tethered IL-12 repolarizes the tumor immune ...
JCI Insight - Targeting the undruggable oncogenic KRAS: the dawn of hope
A light-driven dual-nanotransformer with deep tumor penetration for ...
XLID syndrome gene Med12 promotes Ig isotype switching through ...
Oncology Letters
Frontiers | Radiation-Induced Secondary Cancer Risk Assessment in ...
Frontiers | Reprogramming of IL-12 secretion in the PDCD1 locus ...
Tumor-targeted IL-12 combined with tumor resection yields a survival ...
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the ...
Local Interleukin-12 Treatment Enhances the Efficacy of Radiation ...
Intratumoral Plasmid IL12 Expands CD8 + T Cells and Induces a CXCR3 ...
Deep, noninvasive imaging and surgical guidance of submillimeter tumors ...
Gene therapy with a single chain interleukin 12 fusion protein induces ...
Rapid Visualization of Human Tumor Xenografts through Optical Imaging ...
The Antibody-Based Delivery of Interleukin-12 to the Tumor ...
Preclinical and clinical evaluation of intratumoral injection of an IL ...
Control of large, established tumor xenografts with genetically ...
GRAPHIC
Characterization of sig12D-LODER devices and injection procedure (a ...
“新概念”抗癌药，打破“不可成药”魔咒，拓宽靶向治疗路径 - 知乎
RNAi therapy targeting KRAS in combination with chemotherapy for ...
A. Study design. B. siG12D-LODER TM is placed with Endoscopic US biopsy ...
Schematic Illustrations of the siRNABased Therapeutics of CALAA-01 and ...
A. Overall survival: Kaplan-Meier curves depict OS of siG12D-LODER ...
siG12D-LODER(siG12D-LODER) - 药物靶点：KRAS G12D_专利_临床_研发
助力Kras，p53癌基因研究，“药"更近一步！ - 知乎
聚焦药靶：KRAS大战一触即发，谁能笑到最后？|KRAS|G12C|抑制剂|肿瘤|-健康界
Silenseed -LODER Loading Device - Blank innovations
KRAS G12D基因突变是什么意思？针对KRAS G12D的靶向药有哪些？临床试验什么时候能上市？ - 知乎
最新！最全！KRAS G12D突变临床在研靶向药物进展一览 - 知乎
Novel Treatment Approaches for Locally Advanced Pancreatic Cancer
Multistep, effective drug distribution within solid tumors | Oncotarget
Multistep, effective drug distribution within solid tumors - PMC
Targeting RAF dimers in RAS mutant tumors: From biology to clinic - PMC
Three ‘E’ challenges for siRNA drug development: Trends in Molecular ...
Advances in the delivery of RNA therapeutics: from concept to clinical ...
Schemes of representative clinically studied siRNA formulations and ...
Elevation of ADAM12 facilitates tumor progression by enhancing ...
Intraductal xenografts show lobular carcinoma cells rely on their own ...
Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti ...
Next generation therapies for pancreatic cancer - PMC
ct changes from base-line: the difference in the ct measurements shown ...
$加科思-B(01167)$ KRAS G12D突变靶向治疗研究进展 2024-03-20 17:54 江苏 作者叶小彤... - 雪球
打破KRAS靶点“不可成药”难题？一文总结KRAS G12C/G12D靶向药物临床研究进展！3款已上市，多款临床招募中 - 知乎
(PDF) RNAi therapy targeting KRAS in combination with chemotherapy for ...
基因治疗行业深度报告：千亿市场大有可为
颠覆40年困境！2026年重磅聚焦：KRAS靶点全面破局，KRAS G12D/泛突变抑制剂临床突破全景、深度解读 - 北京凯石国际医疗技术有限公司
Informa Pharma Intelligence - ppt download
全球30家主要小核酸药物研发公司盘点医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
